Defense Secretary Pete Hegseth faces a second day of grilling from Democrats on Capitol Hill, with senators getting their first opportunity to confront or praise the Pentagon chief over his handling o ...
Nuvalent is positioned as a high-quality late-stage biotech with two near-commercial precision oncology assets. Read more on ...
Hegseth described lawmakers who criticize the war with Iran as “the biggest adversary.” Meanwhile, sources say Pakistan could ...
But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty of strategies for discovering value stocks, but we have found ...
Iran said on Thursday it would respond with "long and painful strikes" on US positions if Washington renewed attacks, and ...
Obexelimab Phase 3 win, SLE catalyst, pipeline updates (ZB014, orelabrutinib), and cash runway—read now. Click for a ZBIO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results